Healthcare Equipment and Supplies
Company Overview of Rna Diagnostics Inc.
Rna Diagnostics Inc. develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company has clinical trials and collaborations in progress at multiple clinical research centers in Canada, Germany, Italy, Japan, Sweden, the United Kingdom, and the United States. Rna Diagnostics Inc. was founded in 2010 and is based in Toronto, Canada with a RNA diagnostics’ laboratory in Sudbury, Canada.
101 College Street
Toronto, ON M5G 1L7
Founded in 2010
Key Executives for Rna Diagnostics Inc.
Rna Diagnostics Inc. Key Developments
Similar Private Companies By Industry
|7D Surgical, Inc.||Americas|
|A.R. Medicom, Inc.||Americas|
|ABK Biomedical Inc.||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Rna Diagnostics Inc., please visit www.rnadiagnostics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.